SCHEMBL9637031

SCHEMBL9637031

O=c1oc2c(OCc3cccc(OCc4ccc5ccccc5n4)c3)cccc2cc1-c1nnn[nH]1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 2/20 0.48
GPBAR1 Q8TDU6 1/20 0.48
CYSLTR2 Q9NS75 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7716669 0.87 CYSLTR1 (0.55) CYSLTR1GPBAR1CYSLTR2
SCHEMBL9637051 0.84 CYSLTR1 (0.51) CYSLTR1GPBAR1CYSLTR2
SCHEMBL7010321 0.80 CYSLTR1 (0.60) CYSLTR1GPBAR1CYSLTR2
SCHEMBL9818450 0.80 CYSLTR1 (0.52) CYSLTR1GPBAR1CYSLTR2
SCHEMBL6089355 0.79 CYSLTR1 (0.57) CYSLTR1GPBAR1CYSLTR2
SCHEMBL11021870 0.79 ADORA3 (0.48)
SCHEMBL7717069 0.79 CYSLTR1 (0.57) CYSLTR1GPBAR1CYSLTR2
SCHEMBL9636885 0.79 CYSLTR1 (0.53) CYSLTR1GPBAR1CYSLTR2
SCHEMBL9635560 0.79 CYSLTR1 (0.57) CYSLTR1GPBAR1CYSLTR2
SCHEMBL9757016 0.78 CYSLTR1 (0.52) CYSLTR1GPBAR1CYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5082849-A Antiinflammatory agents or antiallergens AVENTIS PHARMACEUTICALS INC. 1992-01-21 US disclosed
EP-0434827-A4 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? 1992-01-08 EP disclosed
EP-0434827-A1 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-07-03 EP disclosed
WO-1991001123-A2 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? RORER INTERNATIONAL (OVERSEAS) INC. (US) 1991-02-07 WO disclosed